Key result
HFA-PEFF showed higher sensitivity and concordance than H2FPEF against physician-adjudicated HFpEF in Haiti.
Why the study?
HFpEF is rapidly increasing in low- and middle-income countries where detection remains challenging, and the diagnostic performance of screening scores developed in high-income settings needed evaluation against physician-adjudicated HFpEF.
Do the H2FPEF and HFA-PEFF screening scores accurately detect prevalent HFpEF compared to physician adjudication in a low-income population-based cohort in Haiti?
Cross-Sectional (n=3,003)
Do the H2FPEF and HFA-PEFF screening scores accurately detect prevalent HFpEF compared to physician adjudication in a low-income population-based cohort in Haiti?
Answers are grounded in this paper and cite their sources.
In a Haitian population cohort where HFpEF presents at a younger age with high hypertension/obesity and negligible atrial fibrillation, the HFA-PEFF score demonstrated better sensitivity and agreement with physician adjudication than H2FPEF, highlighting the need for tailored non-invasive screening tools in low-income settings.
BACKGROUND: Heart failure with preserved ejection fraction (HFpEF) is rapidly increasing in low- and middle-income countries, however detection remains challenging. We assessed 2 screening scores developed in high-income settings, H2FPEF and HFA-PEFF, against physician-adjudicated HFpEF in a population-based cohort from Haiti. METHODS: The primary outcome was prevalent HFpEF defined by (1) physician adjudication, (2) H2FpEF score, (3) HFA-PEFF score. The cross-sectional cohort comprised 3003 adults from the Haiti Cardiovascular Disease Cohort, with sociodemographic, clinical, electrocardiography, echocardiography and BNP data available. We compared physician-adjudicated HFpEF participants to those screening positive (intermediate-high H2FPEF and HFA-PEFF scores) using interrater reliability (Cohen's kappa, Krippendorff's alpha). Diagnostic performance of H2FPEF and HFA-PEFF against physician adjudication, used as a pragmatic reference standard appropriate for Haiti and similar settings, was calculated via sensitivity, specificity, and predictive values. RESULTS: Age-adjusted HFpEF prevalence was 9.5% (95% CI: 8.3-11.0) by physician adjudication, 10.2% (95% CI: 9.0-11.7) by H2FPEF, and 8.6% (95% CI: 7.5-10.0) by HFA-PEFF. Adjudicated HFpEF participants were young (median age 57), had high prevalence of hypertension (70%), obesity (33%), and no atrial fibrillation. Agreement between all 3 scores was moderate-substantial (alpha 0.57, 95% CI: 0.55-0.59), with the highest pair-wise agreement between physician adjudication and HFA-PEFF (kappa 0.62, 95% CI: 0.57-0.67). HFA-PEFF had higher sensitivity and similar specificity relative to H2FPEF. CONCLUSIONS: In this Haitian cohort, prevalent HFpEF occurred in relatively young participants with high hypertension and obesity rates and negligible atrial fibrillation. HFA-PEFF exhibited higher concordance and sensitivity than H2FPEF versus physician adjudication. Tailored, non-invasive HFpEF screening scores for low- and middle-income countries are needed to address this growing global epidemic.
No takes yet. Share an insight, caveat, or question.
Yan et al. (2026) conducted a cross-sectional in Heart failure with preserved ejection fraction (HFpEF) (n=3,003). H2FPEF and HFA-PEFF screening scores vs. Physician-adjudicated HFpEF was evaluated on Prevalent HFpEF defined by physician adjudication, H2FPEF score, and HFA-PEFF score (kappa 0.62, 95% CI 0.57-0.67). HFA-PEFF showed higher sensitivity and concordance than H2FPEF against physician-adjudicated HFpEF in Haiti.
Synapse has enriched 10 related papers. Consider them for comparative context: